Exalenz Bioscience

Exalenz Bioscience commercializes the BreathID System which extracts vital information for diagnostics.

Launch date

2006

Employees

Market cap

Enterprise valuation

€45m (Public information from Feb 2020)

Rosh Haayin Center District (HQ)

http://exalenz.com

https://twitter.com/exalenz https://www.facebook.com/breathid https://www.linkedin.com/company/exalenz-bioscience-ltd.

Authorizing premium user...